scholarly journals Ibrutinib: a first in class covalent inhibitor of Bruton's tyrosine kinase

2014 ◽  
Vol 10 (6) ◽  
pp. 957-967 ◽  
Author(s):  
Matthew S Davids ◽  
Jennifer R Brown
2020 ◽  
Vol 63 (10) ◽  
pp. 5102-5118 ◽  
Author(s):  
Daniela Angst ◽  
François Gessier ◽  
Philipp Janser ◽  
Anna Vulpetti ◽  
Rudolf Wälchli ◽  
...  

2017 ◽  
Vol 83 (11) ◽  
pp. 2367-2376 ◽  
Author(s):  
Patrick F. Smith ◽  
Janakan Krishnarajah ◽  
Philip A. Nunn ◽  
Ron J. Hill ◽  
Dane Karr ◽  
...  

2021 ◽  
Author(s):  
Angus Voice ◽  
Gary Tresdern ◽  
Rebecca M Twidale ◽  
Herman Van Vlijmen ◽  
Adrian John Mulholland

Ibrutinib is the first covalent inhibitor of Bruton’s tyrosine kinase (BTK) to be used in the treatment of B-cell cancers. Understanding the mechanism of covalent inhibition will aid in the...


2019 ◽  
Vol 62 (17) ◽  
pp. 7923-7940 ◽  
Author(s):  
Yunhang Guo ◽  
Ye Liu ◽  
Nan Hu ◽  
Desheng Yu ◽  
Changyou Zhou ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document